The artificial urinary sphincter (AUS) remains the benchmark for surgical management in male stress urinary incontinence (SUI), particularly following prostate surgery. The device, which replicates ...

UroMems is set to enter the pivotal trial phase with its device for treating stress urinary incontinence (SUI). The company was awarded an investigational device exemption (IDE) from the US Food and ...

Uromems, the company developing an automated artificial urinary sphincter implant for both men and women with stress urinary incontinence (SUI), hit a significant milestone. The Grenoble, France-based ...

This retrospective review evaluated outcomes of penoscrotal (PS) and perineal artificial urinary sphincter (AUS) placement. A total of 120 patients available for follow-up underwent single-cuff AUS ...

Stress urinary incontinence (SUI) in women represents a significant clinical challenge, often undermining quality of life and daily functioning. While midurethral slings currently constitute the ...

Affluent Medical SA said that its artificial sphincter, Artus, which treats stress urinary incontinence, was successfully implanted into the first patient. The company hopes that the device, which is ...

For people with idiopathic chronic non-obstructive urinary retention caused by external urethral sphincter dysfunction (also known as Fowler’s syndrome in younger women and people with female anatomy, ...

The Global Artificial Urinary Sphincter Market Size is expected to be worth US$ 459.8 million in 2023, expanding at a 5.2% CAGR. In 2033, it is expected to be valued US$ 760.5 million. The rising use ...

In the realm of medical innovation, the global artificial urinary sphincter market shines as a beacon of hope and progress. Anticipated to be valued at USD 459.8 million in 2023 and projected to ...